- Home
- GRVY vs DNA Comparison
GRVY vs DNA Comparison
Compare GRVY & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | DNA |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | South Korea | United States |
| Employees | N/A | 485 |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 423.9M | 455.8M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | GRVY | DNA |
|---|---|---|
| Price | $61.75 | $6.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 19.3K | ★ 1.2M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $54.54 | $5.00 |
| 52 Week High | $74.75 | $17.58 |
Technical Indicators
Market Signals| Indicator | GRVY | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 50.75 | 40.53 |
| Support Level | $61.06 | $6.26 |
| Resistance Level | $65.27 | $7.10 |
| Average True Range (ATR) | 1.96 | 0.46 |
| MACD | 0.20 | 0.10 |
| Stochastic Oscillator | 77.98 | 12.95 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.